Literature DB >> 32492121

Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review.

Ton Wang1,2, Alison S Baskin1, Lesly A Dossett1,2.   

Abstract

Importance: Overtreatment of early-stage breast cancer results in increased morbidity and cost without improving survival. Major surgical organizations participating in the Choosing Wisely campaign identified 4 breast cancer operations as low value: (1) axillary lymph node dissection for limited nodal disease in patients receiving lumpectomy and radiation, (2) re-excision for close but negative lumpectomy margins for invasive cancer, (3) contralateral prophylactic mastectomy in patients at average risk with unilateral cancer, and (4) sentinel lymph node biopsy in women 70 years or older with hormone receptor-positive cancer. Objective: To evaluate the extent to which these procedures have been deimplemented, determine the implications of decreased use, and recognize possible barriers and facilitators to deimplementation. Evidence Review: A systematic review of published literature on use trends in breast surgery was performed in accordance with PRISMA guidelines. The Ovid, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane databases were searched for original research with relevance to the Choosing Wisely recommendations of interest. Eligible studies were examined for data about use, and any patient-level, clinician-level, or system-level factors associated with use. Findings: Concordant with recommendations, national rates of axillary lymph node dissection for patients with limited nodal disease have decreased by approximately 50% (from 44% in 2011 to 30% to 34% in 2012 and 25% to 28% in 2013), and national rates of lumpectomy margin re-excision have decreased by nearly 40% (from 16% to 34% before to 14% to 18% after publication of a consensus statement). Conversely, national rates of contralateral prophylactic mastectomy continue to rise each year, accounting for up to 30% of all mastectomies for breast cancer (range in all mastectomy cases: 2010-2012, 28%-30%; 1998, <2%), and rates of sentinel lymph node biopsy in women 70 years or older with low-risk breast cancer are persistently greater than 80% (range, 80%-88%). Factors associated with high rates of contralateral prophylactic mastectomy use are younger age, white race, increased socioeconomic status, and the availability of breast reconstruction; limited data exist on factors associated with high rates of sentinel lymph node biopsy in women 70 years or older. Successful deimplementation of axillary lymph node dissection and lumpectomy margin re-excision were associated with decreased costs and improved patient-centered outcomes. Conclusions and Relevance: This review demonstrates variable deimplementation of 4 low-value surgical procedures in patients with breast cancer. Addressing specific patient-level, clinician-level, and system-level barriers to deimplementation is necessary to encourage shared decision-making and reduce overtreatment.

Entities:  

Mesh:

Year:  2020        PMID: 32492121     DOI: 10.1001/jamasurg.2020.0322

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   16.681


  21 in total

1.  ASO Author Reflections: Can Medical Maximizing-Minimizing Preferences Inform De-implementation Efforts for Low-Value Breast Cancer Services in Older Women?

Authors:  Nicole Mott; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-08-05       Impact factor: 5.344

Review 2.  Breast Cancer Disparities and the Impact of Geography.

Authors:  Samilia Obeng-Gyasi; Barnabas Obeng-Gyasi; Willi Tarver
Journal:  Surg Oncol Clin N Am       Date:  2021-10-19       Impact factor: 3.495

3.  Using Tailored Messages to Target Overuse of Low-Value Breast Cancer Care in Older Women.

Authors:  Lesly A Dossett; Nicole M Mott; Brooke C Bredbeck; Ton Wang; Chad Tc Jobin; Tasha M Hughes; Sarah T Hawley; Brian J Zikmund-Fisher
Journal:  J Surg Res       Date:  2021-11-19       Impact factor: 2.192

4.  Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.

Authors:  Jonas A Nelson; Robyn N Rubenstein; Kathryn Haglich; Jacqueline J Chu; Shen Yin; Carrie S Stern; Monica Morrow; Babak J Mehrara; Mary L Gemignani; Evan Matros
Journal:  JAMA Surg       Date:  2022-08-01       Impact factor: 16.681

5.  A Health Systems Ethical Framework for De-implementation in Health Care.

Authors:  Alison S Baskin; Ton Wang; Jacquelyn Miller; Reshma Jagsi; Eve A Kerr; Lesly A Dossett
Journal:  J Surg Res       Date:  2021-06-18       Impact factor: 2.192

6.  Medical Maximizing-Minimizing Preferences in Relation to Low-Value Services for Older Women with Hormone Receptor-Positive Breast Cancer: A Qualitative Study.

Authors:  Nicole Mott; Ton Wang; Jacquelyn Miller; Nicholas L Berlin; Sarah Hawley; Reshma Jagsi; Brian J Zikmund-Fisher; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

7.  Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.

Authors:  Ton Wang; Alison Baskin; Jacquelyn Miller; Allan Metz; Niki Matusko; Tasha Hughes; Michael Sabel; Jacqueline S Jeruss; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

8.  Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence.

Authors:  Heloisa Magda Resende; Martina Lichtenfels; Igor Camargo Soares; Angélica Araújo Cortines Laxe Renó; Ana Paula Cunha; Pedro Gustavo Falcão; Carolina Soares Pimentel Pieroni; Biazi Ricieri de Assis; Paola Cardoso; Pedro Henrique Adário Marassi; Rafael Dos Santos Reis
Journal:  Acta Cir Bras       Date:  2021-07-02       Impact factor: 1.388

9.  The risk of contralateral breast cancer: a SEER-based analysis.

Authors:  Vasily Giannakeas; David W Lim; Steven A Narod
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075

10.  Gaps in Online Breast Cancer Treatment Information for Older Women.

Authors:  Alison S Baskin; Ton Wang; Nicole M Mott; Sarah T Hawley; Reshma Jagsi; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-07-30       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.